Does OSIMERTINIB Cause Febrile neutropenia? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Febrile neutropenia have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.
37
Reports of Febrile neutropenia with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
4
Deaths
28
Hospitalizations
How Dangerous Is Febrile neutropenia From OSIMERTINIB?
Of the 37 reports, 4 (10.8%) resulted in death, 28 (75.7%) required hospitalization, and 10 (27.0%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which OSIMERTINIB Alternatives Have Lower Febrile neutropenia Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN